Moderna | MRNA - Debt


Moderna reported $1.31B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 52.19M 2.62M Dec/2025
Agios Pharmaceuticals USD 40.21M 4.31M Dec/2025
Alnylam Pharmaceuticals USD 1.28B 30.06M Dec/2025
Amgen USD 54.6B 17M Dec/2025
Arrowhead Research USD 312.77M 53.52M Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
BioMarin Pharmaceutical USD 1.44B 833.74M Mar/2026
Celltrion KRW 161.31B 9.78B Dec/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Incyte USD 39.43M 982K Mar/2026
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Moderna USD 1.31B 571M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 47.54M 1.88M Mar/2026
Puma Biotechnology USD 89.06M 55.07M Jun/2024
Qiagen NV USD 1.81B 314.82M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 300K Mar/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 1.04B 210.44M Dec/2025
Sartorius EUR 4.28B 372.9M Dec/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Ultragenyx Pharmaceutical USD 36M 2.17M Dec/2025
United Therapeutics USD 200M 100M Mar/2025
Vertex Pharmaceuticals USD 1.99B 44M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026